<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1243" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1243/" /><meta name="ncbi_pagename" content="ALS2-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>ALS2-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="ALS2-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/01/28" /><meta name="citation_author" content="Richard W Orrell" /><meta name="citation_pmid" content="20301421" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1243/" /><meta name="citation_keywords" content="Infantile-onset Ascending Hereditary Spastic Paralysis" /><meta name="citation_keywords" content="Autosomal Recessive Juvenile Amyotrophic Lateral Sclerosis" /><meta name="citation_keywords" content="Juvenile Primary Lateral Sclerosis" /><meta name="citation_keywords" content="Alsin" /><meta name="citation_keywords" content="ALS2" /><meta name="citation_keywords" content="ALS2-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="ALS2-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Richard W Orrell" /><meta name="DC.Date" content="2016/01/28" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1243/" /><meta name="description" content="ALS2-related disorders involve retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprise a clinical continuum from infantile ascending hereditary spastic paraplegia (IAHSP), to juvenile forms without lower motor neuron involvement (juvenile primary lateral sclerosis [JPLS]), to forms with lower motor neuron involvement (autosomal recessive juvenile amyotrophic lateral sclerosis [JALS])." /><meta name="og:title" content="ALS2-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="ALS2-related disorders involve retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprise a clinical continuum from infantile ascending hereditary spastic paraplegia (IAHSP), to juvenile forms without lower motor neuron involvement (juvenile primary lateral sclerosis [JPLS]), to forms with lower motor neuron involvement (autosomal recessive juvenile amyotrophic lateral sclerosis [JALS])." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1243/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/iahsp/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1243/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88BA18E0425F9100000000025D00E5.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1243_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1243_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alk-nbs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ankrd26/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1243_"><span class="title" itemprop="name"><i>ALS2</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Richard W Orrell</span>, BSc, MD, FRCP.</p><a data-jig="ncbitoggler" href="#__NBK1243_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1243_ai__"><div class="contrib half_rhythm"><span itemprop="author">Richard W Orrell</span>, BSc, MD, FRCP<div class="affiliation small">University Department of Clinical Neurosciences<br />Institute of Neurology<br />University College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@llerro.r" class="oemail">ku.ca.lcu@llerro.r</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 21, 2005</span>; Last Update: <span itemprop="dateModified">January 28, 2016</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="iahsp.Summary" itemprop="description"><h2 id="_iahsp_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>ALS2</i>-related disorders involve retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprise a clinical continuum from infantile ascending hereditary spastic paraplegia (IAHSP), to juvenile forms without lower motor neuron involvement (juvenile primary lateral sclerosis [JPLS]), to forms with lower motor neuron involvement (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> juvenile amyotrophic lateral sclerosis [JALS]).</p><ul><li class="half_rhythm"><div>IAHSP is characterized by onset of spasticity with increased reflexes and sustained clonus of the lower limbs within the first two years of life, progressive weakness and spasticity of the upper limbs by age seven to eight years, and wheelchair dependence in the second decade with progression toward severe spastic tetraparesis and a pseudobulbar syndrome.</div></li><li class="half_rhythm"><div>JPLS is characterized by onset and loss of ability to walk during the second year of life, progressive signs of upper motor neuron disease, wheelchair dependence by adolescence, and later loss of motor speech production.</div></li><li class="half_rhythm"><div>JALS is characterized by onset during childhood (mean age of onset 6.5 years), spasticity of facial muscles, uncontrolled laughter, spastic dysarthria, spastic gait, moderate muscle atrophy (variably present), bladder dysfunction, and sensory disturbances; some individuals are bedridden by age 12 to 50 years.</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Results of electrophysiology studies in <i>ALS2</i>-related disorders vary by <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>; MRI shows brain changes in older individuals with IAHSP. Pathogenic variants in <i>ALS2</i> have been found in four of 11 families with IAHSP; no other genes/loci are known to be associated with these disorders.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Physical and occupational therapy to promote mobility and independence and use of computer technologies and devices to facilitate writing and voice communication.</p><p><i>Prevention of secondary complications:</i> Early detection and treatment of hip dislocation and/or spine deformities prevent further complications.</p><p><i>Surveillance</i>: Evaluation for feeding difficulties and modification of diet to reduce risk of aspiration.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>ALS2</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if both pathogenic variants have been identified in an affected family member.</p></div></div><div id="iahsp.GeneReview_Scope"><h2 id="_iahsp_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="iahsp.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1243/table/iahsp.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__iahsp.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_iahsp.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>ALS2</i>-Related Disorders: Included Phenotypes <sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_iahsp.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Infantile-onset ascending hereditary spastic paralysis</div></li><li class="half_rhythm"><div>Juvenile primary lateral sclerosis</div></li><li class="half_rhythm"><div>Autosomal recessive juvenile amyotrophic lateral sclerosis</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="iahsp.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#iahsp.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="iahsp.Diagnosis"><h2 id="_iahsp_Diagnosis_">Diagnosis</h2><p><i>ALS2</i>-related disorders involve retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprise a clinical continuum that includes:</p><ul><li class="half_rhythm"><div>Infantile ascending hereditary spastic paraplegia (IAHSP),*</div></li><li class="half_rhythm"><div>Juvenile forms without lower motor neuron involvement (juvenile primary lateral sclerosis, or JPLS),* and</div></li><li class="half_rhythm"><div>Forms with lower motor neuron involvement (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> juvenile amyotrophic lateral sclerosis, or JALS).</div></li></ul><p>The different phenotypes reported in the literature are summarized.</p><p>*Note: In some instances, the same entity may be called either juvenile primary lateral sclerosis or IAHSP.</p><div id="iahsp.Suggestive_Findings"><h3>Suggestive Findings</h3><p>An <i>ALS2</i>-related disorder <b>should be suspected</b> in individuals with the following phenotypes, electrophysiologic findings, and neuroimaging findings:</p><div id="iahsp.Phenotypes"><h4>Phenotypes</h4><p><b>Infantile-onset ascending hereditary spastic paralysis (IAHSP)</b> is characterized by the following features [<a class="bk_pop" href="#iahsp.REF.lesca.2003.674">Lesca et al 2003</a>]:</p><ul><li class="half_rhythm"><div>Onset of spasticity with increased reflexes and sustained clonus of the lower limbs within the first two years of life</div></li><li class="half_rhythm"><div>Progressive weakness and spasticity of the upper limbs by age seven to eight years</div></li><li class="half_rhythm"><div>Wheelchair dependence in the second decade, with progression toward severe spastic tetraparesis and a pseudobulbar syndrome</div></li><li class="half_rhythm"><div>Preservation of cognitive function</div></li></ul><p><b>Juvenile primary lateral sclerosis (JPLS)</b> is characterized by the following features [<a class="bk_pop" href="#iahsp.REF.gascon.1995.313">Gascon et al 1995</a>, <a class="bk_pop" href="#iahsp.REF.yang.2001.160">Yang et al 2001</a>]:</p><ul><li class="half_rhythm"><div>Onset during the second year of life</div></li><li class="half_rhythm"><div>Loss of ability to walk in the second year of life</div></li><li class="half_rhythm"><div>Slowly progressive uncomplicated signs of upper motor neuron disease</div></li><li class="half_rhythm"><div>Wheelchair dependence by adolescence</div></li><li class="half_rhythm"><div>Later loss of motor speech production</div></li><li class="half_rhythm"><div>Preservation of cognitive function</div></li></ul><p><b>Autosomal recessive juvenile amyotrophic lateral sclerosis (JALS)</b> (also known as ALS2) is characterized by the following features [<a class="bk_pop" href="#iahsp.REF.ben_hamida.1990.347">Ben Hamida et al 1990</a>]:</p><ul><li class="half_rhythm"><div>Onset during childhood (mean age of onset 6.5 years; range 3-20 years)</div></li><li class="half_rhythm"><div>Spasticity of facial muscles with uncontrolled laughter and spastic dysarthria; spastic gait; in some individuals, mild atrophy of the legs and hands</div></li><li class="half_rhythm"><div>Variably present moderate muscle atrophy, absence of fasciculations, bladder dysfunction, and sensory disturbances</div></li><li class="half_rhythm"><div>Some individuals bedridden by age 12 to 50 years (no information is available on age of wheelchair dependence)</div></li><li class="half_rhythm"><div>Preservation of cognitive function not confirmed</div></li></ul></div><div id="iahsp.Electrophysiologic_Findings"><h4>Electrophysiologic Findings</h4><p><a class="figpopup" href="/books/NBK1243/table/iahsp.T.electrophysiologic_studies_in_al/?report=objectonly" target="object" rid-figpopup="figiahspTelectrophysiologicstudiesinal" rid-ob="figobiahspTelectrophysiologicstudiesinal">Table 1</a> shows the results of various electrophysiologic studies in the different phenotypes of <i>ALS2</i>-related disorders.</p><div id="iahsp.T.electrophysiologic_studies_in_al" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Electrophysiologic Studies in <i>ALS2</i>-Related Disorders by Phenotype</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1243/table/iahsp.T.electrophysiologic_studies_in_al/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__iahsp.T.electrophysiologic_studies_in_al_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_1" style="text-align:left;vertical-align:middle;">Study</th><th id="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th></tr><tr><th headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2" id="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">IAHSP</th><th headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2" id="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">JPLS</th><th headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2" id="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">JALS</th></tr></thead><tbody><tr><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>MEP</b></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe dysfunction of the corticospinal tracts&#x000a0;<sup>1</sup></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent or reduced action potential, suggesting dysfunction of corticospinal tracts&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>SSEP</b></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal in early stages; abnormal in later stages</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Poorly configured; normal central conduction</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>EMG</b></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No signs of denervation</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No signs of denervation</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Signs of denervation</td></tr><tr><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>NCV</b></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td></tr><tr><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>VEP</b></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>BAER</b></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>TCMS</b></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No motor evoked potentials</td><td headers="hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_1_2 hd_h_iahsp.T.electrophysiologic_studies_in_al_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">BAER = brain stem auditory evoked potentials; EMG = electromyography; MEP = motor evoked potentials; NA = not available; NCV = nerve conduction velocities; SSEP = somatosensory evoked potentials; TCMS = transcranial magnetic stimulation; VEP = visual evoked potentials</p></div></dd><dt>1. </dt><dd><div id="iahsp.TF.1.1"><p class="no_margin">Primitive, pure degeneration of the upper motor neurons</p></div></dd><dt>2. </dt><dd><div id="iahsp.TF.1.2"><p class="no_margin"><a class="bk_pop" href="#iahsp.REF.kress.2005.800">Kress et al [2005]</a></p></div></dd></dl></div></div></div></div><div id="iahsp.Neuroimaging_Findings"><h4>Neuroimaging Findings</h4><p><b>IAHSP.</b> Magnetic resonance imaging (MRI) is normal in children.</p><p>Older individuals have:</p><ul><li class="half_rhythm"><div>Brain cortical atrophy predominant in the motor areas</div></li><li class="half_rhythm"><div>T<sub>2</sub>-weighted bilateral punctate hyperintense signals in the corticospinal pathways of the posterior arms of the internal capsule and brain stem.</div></li></ul><p>In addition, it is common to find T<sub>2</sub>- or FLAIR-weighted hyperintensities of periventricular areas and aspects of spinal cervical atrophy that are often seen in other <a href="/books/n/gene/hsp/">hereditary spastic paraplegias</a> (HSPs).</p><p><b>JPLS.</b> CT and MRI scans of brain and spinal cord are normal.</p><p><b>JALS.</b> MRI studies of brain and spinal cord are normal [<a class="bk_pop" href="#iahsp.REF.kress.2005.800">Kress et al 2005</a>, <a class="bk_pop" href="#iahsp.REF.shirakawa.2009.2124">Shirakawa et al 2009</a>].</p></div></div><div id="iahsp.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of an <i>ALS2</i>-related disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ALS2</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1243/table/iahsp.T.electrophysiologic_studies_in_al/?report=objectonly" target="object" rid-figpopup="figiahspTelectrophysiologicstudiesinal" rid-ob="figobiahspTelectrophysiologicstudiesinal">Table 1</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>ALS2</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found. Note that while no <i>ALS2</i> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications have been reported to date, loss of <i>ALS2</i> function due to these mechanisms would be expected to cause disease; thus, use of gene-targeted deletion/duplication analysis in this instance is a reasonable option.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ALS2</i> and other genes of interest (see <a href="#iahsp.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="iahsp.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>ALS2</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1243/table/iahsp.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__iahsp.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_iahsp.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_iahsp.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_iahsp.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_iahsp.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALS2</i></td><td headers="hd_h_iahsp.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_iahsp.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All sequence variants reported to date</td></tr><tr><td headers="hd_h_iahsp.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_iahsp.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="iahsp.TF.2.1"><p class="no_margin">See <a href="/books/NBK1243/#iashp.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="iahsp.TF.2.2"><p class="no_margin">See <a href="#iahsp.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="iahsp.TF.2.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="iahsp.TF.2.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="iahsp.TF.2.5"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available; however, loss of <i>ALS2</i> function due to a large deletion or duplication is expected to cause disease.</p></div></dd></dl></div></div></div></div></div><div id="iahsp.Clinical_Characteristics"><h2 id="_iahsp_Clinical_Characteristics_">Clinical Characteristics</h2><div id="iahsp.Clinical_Description"><h3>Clinical Description</h3><p>Pathogenic variants in <i>ALS2</i> are responsible for a retrograde degeneration of the upper motor neurons of the pyramidal tracts, leading to a clinical continuum from infantile ascending hereditary spastic paraplegia to juvenile forms without lower motor neuron involvement (juvenile primary lateral sclerosis) or with lower motor neuron involvement (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> juvenile amyotrophic lateral sclerosis).</p><p><b>Infantile ascending hereditary spastic paraplegia (IAHSP).</b> Spastic paraplegia begins during the first two years of life and extends to upper limbs within the next few years. Manifestations of the disease may start as early as the first year of life. During the first decade of life, the disease progresses to tetraplegia, anarthria, dysphagia, and slow eye movements.</p><p>Feeding difficulties, especially in swallowing liquids, may manifest in the second decade; however, those few individuals with long-term follow up who have reached their 30s have neither experienced recurrent bronchopneumonia nor required feeding gastrostomy. Some individuals are reported to require feeding by gastrostomy tube and to lose bladder and sphincter functions in the advanced state [<a class="bk_pop" href="#iahsp.REF.verschuurenbemelmans.2008.1407">Verschuuren-Bemelmans et al 2008</a>].</p><p>Overall, IAHSP is compatible with long survival. Cognitive function is preserved.</p><p><b>Juvenile primary lateral sclerosis (JPLS).</b> Examination reveals upper motor neuron findings of pseudobulbar palsy and spastic quadriplegia without dementia or cerebellar, extrapyramidal, or sensory signs. In addition, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals exhibit a diffuse conjugate saccadic gaze paresis, especially severe on downgaze. Some of these children are never able to walk independently, while others are delayed in walking and then lose the ability to walk independently by the first decade of life. Speech deterioration starts between ages two and ten years. No cognitive deterioration is reported. Survival is variable.</p><p>Intrafamilial variability can be considerable: in one family with two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs with onset in early childhood, one began using a wheelchair at age two years (and was alive at age 42 years); the other began using a wheelchair at age 50 years (and was alive at age 55 years) [<a class="bk_pop" href="#iahsp.REF.mintchev.2009.28">Mintchev et al 2009</a>].</p><p><b>Autosomal recessive juvenile amyotrophic lateral sclerosis (JALS or ALS2)</b> [<a class="bk_pop" href="#iahsp.REF.ben_hamida.1990.347">Ben Hamida et al 1990</a>, <a class="bk_pop" href="#iahsp.REF.hentati.1994.425">Hentati et al 1994</a>]. Onset is between ages three and 20 years. All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> show a spastic pseudobulbar syndrome together with spastic paraplegia. Peroneal muscular atrophy is observed in some, but not all, individuals. Atrophy or fasciculation of the tongue does not occur. At the time of the description of clinical symptoms, three individuals from one family were bedridden by age 12, 20, and 50 years, but another remained ambulatory until age 50 years.</p><p><b>Other.</b> Two families with <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <i>ALS2</i> pathogenic variants have been reported to demonstrate generalized dystonia and cerebellar signs [<a class="bk_pop" href="#iahsp.REF.sheerin.2014.1065">Sheerin et al 2014</a>].</p></div><div id="iahsp.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Both IAHSP and JPLS have been associated with truncating <i>ALS2</i> variants. Generally, the IAHSP and JPLS phenotypes are uniform within families (based on data regarding individuals from 9 families).</p></div><div id="iahsp.Nomenclature"><h3>Nomenclature</h3><p>See <a href="/books/n/gene/als-overview/">Amyotrophic Lateral Sclerosis Overview</a>.</p></div><div id="iahsp.Prevalence"><h3>Prevalence</h3><p>No data on prevalence are available, but <i>ALS2</i>-related disorders are probably currently underdiagnosed.</p><p><i>ALS2</i>-related disorders have been described in individuals from a variety of ethnic backgrounds.</p></div></div><div id="iahsp.Genetically_Related_Allelic_Disord"><h2 id="_iahsp_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ALS2</i>.</p></div><div id="iahsp.Differential_Diagnosis"><h2 id="_iahsp_Differential_Diagnosis_">Differential Diagnosis</h2><div id="iahsp.Hereditary_Spastic_Paraplegia_HSP"><h3>Hereditary Spastic Paraplegia (HSP)</h3><p>For a detailed discussion of HSP and the differential diagnosis of HSP, see the <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a>.</p><p>The hereditary spastic paraplegias are clinically and genetically heterogeneous disorders characterized by insidiously progressive lower extremity weakness and spasticity. Hereditary spastic paraplegia may be transmitted in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>, or maternally inherited (mitochondrial) manner.</p><p>Children with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> HSP and with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> onset of spasticity (<a href="/books/n/gene/spg4/">SPG4</a>, caused by pathogenic variants in <i>SPAST</i> encoding spastin and <a href="/books/n/gene/spg3a/">SPG3A</a>, caused by pathogenic variants in <i>ATL1</i> encoding atlastin) have a non-progressive or very slowly progressive course, whereas in the most common presentation of HSP with onset of spasticity and weakness in adulthood, the course is clearly progressive.</p><p><b>IAHSP without <i>ALS2</i> pathogenic variants.</b> Genetic heterogeneity has been demonstrated by <a class="bk_pop" href="#iahsp.REF.lesca.2003.674">Lesca et al [2003]</a> by the fact of only four of 11 families with IAHSP have <i>ALS2</i> pathogenic variants. No other genes/loci causing this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have been identified.</p><p><b>ARHSP.</b> In general, in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> hereditary spastic paraplegia (ARHSP) with onset during childhood, the progression is less severe and spasticity predominates over weakness. Pseudobulbar involvement in <i>ALS2</i>-related disorders clearly delineates it from all the other genetic forms of spastic paraparesis. In contrast, in ARHSP, muscle weakness predominates over spasticity, onset is clearly apparent during the first decade, and involvement of upper limbs and bulbar function is invariable. The role of <i>ALS2</i> pathogenic variants in ARHSP has not yet been investigated.</p><p>Normal brain white matter on MRI rules out the diagnosis of leukodystrophy (see <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>).</p><p>Metabolic investigations rule out other metabolic causes of progressive ARHSP (very long chain fatty acids [see <a href="/books/n/gene/x-ald/">X-Linked Adrenoleukodystrophy</a>], <a href="/books/n/gene/mld/">arylsulfatase A deficiency</a>, mitochondrial dysfunction [see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>]); however, decline in behavior or cognitive function is frequently observed in these conditions.</p><p><b>Primary lateral sclerosis (PLS)</b> is defined as the presence of slowly progressive, uncomplicated signs of upper motor neuron disease in persons in whom all other known causes of spasticity have been eliminated. PLS has been described in adults with an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> degenerative process of the upper motor neurons, with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> occurrence [<a class="bk_pop" href="#iahsp.REF.pringle.1992.495">Pringle et al 1992</a>]. No <i>ALS2</i> pathogenic variants were identified in a study of 51 Dutch persons with adult-onset PLS [<a class="bk_pop" href="#iahsp.REF.brugman.2007.702">Brugman et al 2007</a>].</p><p><a class="bk_pop" href="#iahsp.REF.alsaif.2012.510">Al-Saif et al [2012]</a> described a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> family from Saudi Arabia having four sibs with infantile-onset PLS with severe progression requiring wheelchair by age 12 and associated with a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> splice junction <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (c.499-1G&#x0003e;T) in <i>ERLIN2</i> (OMIM <a href="http://omim.org/entry/611225" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">611225</a>).</p></div><div id="iahsp.Amyotrophic_Lateral_Sclerosis_ALS"><h3>Amyotrophic Lateral Sclerosis (ALS)</h3><p>For a detailed discussion of ALS and the differential diagnosis of ALS, see <a href="/books/n/gene/als-overview/">Amyotrophic Lateral Sclerosis Overview</a>.</p><p>ALS is a progressive neurodegenerative disease involving both the upper motor neurons (UMN) and lower motor neurons (LMN). LMN signs include weakness, muscle wasting, muscle cramps, fasciculations, and eventually hyporeflexia. UMN signs include hyperreflexia, extensor plantar response, increased muscle tone, and weakness in a topographic representation. Approximately 25 genes are currently thought to be associated with ALS; of these, <i>ALS2</i>, <i>SETX</i> (ALS4), and <i>SIGMAR1</i> (ALS16) are associated with juvenile onset [<a class="bk_pop" href="#iahsp.REF.marangi.2015.75">Marangi &#x00026; Traynor 2015</a>].</p><p><b>ALS4</b> is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> form of ALS, with signs and symptoms of both upper and lower motor neuron involvement and onset before age 25 years. This has also been described as a distal hereditary motor neuropathy with pyramidal signs. Individuals with ALS4 usually have onset before age 25 years, a slow rate of progression, and a normal life span [<a class="bk_pop" href="#iahsp.REF.chen.2004.1128">Chen et al 2004</a>]. ALS4 is caused by mutation of <i>SETX</i>.</p><p><b>ALS5</b> (also known as type 1 <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> ALS) very closely resembles typical ALS of any age of onset and is the most prevalent form of autosomal recessive ALS, having been identified in several ethnic groups (North African, South Asian, and European). This form of recessive ALS was mapped to 15q by <a class="bk_pop" href="#iahsp.REF.hentati.1998.55">Hentati et al [1998]</a>.</p><p><b>ALS16.</b>
<a class="bk_pop" href="#iahsp.REF.alsaif.2011.913">Al-Saif et al [2011]</a> reported a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> family from Saudi Arabia with juvenile ALS (onset age 1-2 years, slowly progressing to use of a wheelchair by age 20 years) with a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (c.304G&#x0003e;C, p.Glu102Gln) in <i>SIGMAR1</i> (OMIM <a href="http://omim.org/entry/614373" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614373</a>).</p></div></div><div id="iahsp.Management"><h2 id="_iahsp_Management_">Management</h2><div id="iahsp.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with an <i>ALS2</i>-related disorder, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Family history</div></li><li class="half_rhythm"><div>Neurologic examination, including assessment of eye movements, speech, fine motor and gross motor function, swallowing</div></li><li class="half_rhythm"><div>Detailed dietary and feeding assessment as needed</div></li><li class="half_rhythm"><div>Orthopedic and rehabilitation assessment as needed</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="iahsp.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Physical and occupational therapy to promote mobility and independence</div></li><li class="half_rhythm"><div>Aids for mobility and limb function</div></li><li class="half_rhythm"><div>Use of computer technologies and devices adapted to facilitate writing and voice communication</div></li></ul></div><div id="iahsp.Surveillance"><h3>Surveillance</h3><p>Routine monitoring:</p><ul><li class="half_rhythm"><div>For feeding difficulties and assessment of diet to assure that the risk of aspiration is reduced</div></li><li class="half_rhythm"><div>For early detection and treatment of hip dislocation and/or spine deformities</div></li></ul></div><div id="iahsp.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#iahsp.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="iahsp.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="iahsp.Genetic_Counseling"><h2 id="_iahsp_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="iahsp.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>ALS2</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="iahsp.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>ALS2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with <i>ALS2</i>-related disorders have marked motor disability and have not been known to reproduce.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ALS2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="iahsp.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>ALS2</i> pathogenic variants in the family.</p></div><div id="iahsp.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="iahsp.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ALS2</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for an <i>ALS2</i>-related disorder are possible.</p></div></div><div id="iahsp.Resources"><h2 id="_iahsp_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=infantileonsetascendinghereditaryspasticparalysis" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Infantile-onset ascending hereditary spastic paralysis</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=juvenileprimarylateralsclerosis" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Juvenile primary lateral sclerosis</a></div></li><li class="half_rhythm"><div><b>Amyotrophic Lateral Sclerosis Association (ALS Association)</b></div><div>27001 Agoura Road</div><div>Suite 250</div><div>Calabasas Hills CA 91301-5104</div><div><b>Phone:</b> 800-782-4747 (Toll-free Patient Services); 818-880-9007</div><div><b>Fax:</b> 818-880-9006</div><div><b>Email:</b> alsinfo@alsa-national.org</div><div><a href="http://www.alsa.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.alsa.org</a></div></li><li class="half_rhythm"><div><b>Amyotrophic Lateral Sclerosis Society of Canada</b></div><div>3000 Steeles Avenue East</div><div>Suite 200</div><div>Markham Ontario L3R 4T9</div><div>Canada</div><div><b>Phone:</b> 800-267-4257 (toll-free); 905-248-2052</div><div><b>Fax:</b> 905-248-2019</div><div><a href="http://www.als.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.als.ca</a></div></li><li class="half_rhythm"><div><b>Motor Neurone Disease Association</b></div><div>PO Box 246</div><div>Northampton NN1 2PR</div><div>United Kingdom</div><div><b>Phone:</b> 01604250505</div><div><b>Fax:</b> 01604 624726/638289</div><div><b>Email:</b> enquiries@mndassociation.org</div><div><a href="http://www.mndassociation.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mndassociation.org</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Hereditary-Spastic-Paraplegia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Information Page</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/amyotrophic-lateral-sclerosis" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Amyotrophic lateral sclerosis</a></div></li><li class="half_rhythm"><div><b>Spastic Paraplegia Foundation, Inc.</b></div><div>7700 Leesburg Pike</div><div>Ste 123</div><div>Falls Church VA 22043</div><div><b>Phone:</b> 877-773-4483 (toll-free)</div><div><b>Email:</b> information@sp-foundation.org</div><div><a href="http://sp-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">sp-foundation.org</a></div></li></ul></div><div id="iahsp.Molecular_Genetics"><h2 id="_iahsp_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="iahsp.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>ALS2-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1243/table/iahsp.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__iahsp.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_iahsp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_iahsp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_iahsp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_iahsp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_iahsp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_iahsp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_iahsp.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_iahsp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">ALS2</td><td headers="hd_b_iahsp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57679" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ALS2</i></a></td><td headers="hd_b_iahsp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57679" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q33<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_iahsp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96Q42" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alsin</a></td><td headers="hd_b_iahsp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://alsod.iop.kcl.ac.uk/Als/Overview/gene.aspx?gene_id=ALS2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">alsod/ALS2 genetic mutations</a><br /><a href="http://reseq.biosciencedbc.jp/resequence/GeneDetail.do?targetId=1&#x00026;geneId=EG57679" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALS mutation database (ALS2)</a><br /><a href="http://databases.lovd.nl/shared/genes/ALS2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALS2 database</a></td><td headers="hd_b_iahsp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ALS2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALS2</a></td><td headers="hd_b_iahsp.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ALS2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALS2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="iahsp.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="iahsp.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for ALS2-Related Disorders (<a href="/omim/205100,606352,606353,607225" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1243/table/iahsp.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__iahsp.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/205100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">205100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606352" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606352</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALSIN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606353" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606353</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607225" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607225</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The longer transcript variant of <i>ALS2</i> (<a href="/nuccore/NM_020919.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020919.3</a>) comprises 34 exons in a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> region of 83 kb. Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> gives rise to a 184-kd full-length form of 1,657 amino acids and a smaller, alternatively spliced transcript of 396 amino acids (<a href="/nuccore/NM_001135745.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001135745.1</a>, <a href="/protein/NP_001129217.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001129217.1</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1243/#iahsp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Nearly 50 pathogenic variants, many <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a>, have been reported in individuals with <i>ALS2</i>-related disorders. These variants include frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. See <a href="/books/NBK1243/bin/iahsp-Table3.pdf">Table 3</a> (pdf) and <a class="figpopup" href="/books/NBK1243/figure/iahsp.F1/?report=objectonly" target="object" rid-figpopup="figiahspF1" rid-ob="figobiahspF1">Figure 1</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figiahspF1" co-legend-rid="figlgndiahspF1"><a href="/books/NBK1243/figure/iahsp.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figiahspF1" rid-ob="figobiahspF1"><img class="small-thumb" src="/books/NBK1243/bin/iahsp-Image001.gif" src-large="/books/NBK1243/bin/iahsp-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndiahspF1"><h4 id="iahsp.F1"><a href="/books/NBK1243/figure/iahsp.F1/?report=objectonly" target="object" rid-ob="figobiahspF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Schematic representation of the Alsin protein domain structure with reported amino acid changes indicated Alsin protein with RCC1 (regulator of chromatin condensation)-like domain (RLD), DH/PH (Dbl and pleckstrin homology), and VPS9 (vacuolar protein <a href="/books/NBK1243/figure/iahsp.F1/?report=objectonly" target="object" rid-ob="figobiahspF1">(more...)</a></p></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Sequence comparisons suggest that <i>ALS2</i> encodes the protein alsin which contains three guanine nucleotide exchange factor (GEF) domains: RCC1(regulator of chromatin condensation)-like <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (RLD); the Dbl homology and pleckstrin homology (DH/PH); and the vacuolar protein sorting 9 (VPS9) (see <a class="figpopup" href="/books/NBK1243/figure/iahsp.F1/?report=objectonly" target="object" rid-figpopup="figiahspF1" rid-ob="figobiahspF1">Figure 1</a>). GEF activates one or more small GTPases, facilitating the releasing of GDP and exchange for GTP. Alsin acts as a GEF for Rab5, a GTPase implicated in endosomal trafficking [<a class="bk_pop" href="#iahsp.REF.otomo.2003.1671">Otomo et al 2003</a>, <a class="bk_pop" href="#iahsp.REF.hadano.2007.74">Hadano et al 2007</a>]. Alsin acts on Rac1, a G protein involved in actin cytoskeleton remodeling [<a class="bk_pop" href="#iahsp.REF.topp.2004.24612">Topp et al 2004</a>, <a class="bk_pop" href="#iahsp.REF.kanekura.2005.4532">Kanekura et al 2005</a>], and recruits active Rac1 to membrane ruffles facilitating Rac1-activated endocytosis [<a class="bk_pop" href="#iahsp.REF.kunita.2007.16599">Kunita et al 2007</a>].</p><p>Endogenous alsin is enriched in nerve tissue where it is peripherally bound to the cytoplasmic face of endosomal membranes [<a class="bk_pop" href="#iahsp.REF.otomo.2003.1671">Otomo et al 2003</a>, <a class="bk_pop" href="#iahsp.REF.yamanaka.2003.16041">Yamanaka et al 2003</a>, <a class="bk_pop" href="#iahsp.REF.kunita.2004.38626">Kunita et al 2004</a>, <a class="bk_pop" href="#iahsp.REF.topp.2004.24612">Topp et al 2004</a>]. Alsin is also present in membrane ruffles and lamellipodia [<a class="bk_pop" href="#iahsp.REF.topp.2004.24612">Topp et al 2004</a>], suggesting that alsin is involved in membrane transport events, potentially linking endocytic processes and actin cytoskeleton remodeling.</p><p>The function of alsin in the nervous system has been tested in alsin-deficient mice and the primary neurons from them. Neuropathologic analysis exhibited mild axonal degeneration in the dorsolateral [<a class="bk_pop" href="#iahsp.REF.yamanaka.2006.95">Yamanaka et al 2006</a>] or distal corticospinal tracts [<a class="bk_pop" href="#iahsp.REF.deng.2007.2911">Deng et al 2007</a>, <a class="bk_pop" href="#iahsp.REF.groslouis.2008.2691">Gros-Louis et al 2008</a>], or progressive loss of cerebellar Purkinje cells with decreased number of motor axons from lumbar spinal cord [<a class="bk_pop" href="#iahsp.REF.hadano.2006.233">Hadano et al 2006</a>]. Modest behavioral abnormalities observed in alsin-deficient mice included motor slowness and/or decreased motor coordination measured by rotarod performance [<a class="bk_pop" href="#iahsp.REF.cai.2005.7567">Cai et al 2005</a>, <a class="bk_pop" href="#iahsp.REF.deng.2007.2911">Deng et al 2007</a>, <a class="bk_pop" href="#iahsp.REF.yamanaka.2006.95">Yamanaka et al 2006</a>]. Alsin-deficient mice have normal life span and a far milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than that observed in humans with <i>ALS2</i> pathogenic variants.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Mutated alsin and a naturally truncated alsin isoform are rapidly degraded when expressed in cultured human cells, including lymphocytes and fibroblasts derived from individuals with <i>ALS2</i> pathogenic variants. Thus, pathogenic variants in <i>ALS2</i> linked to early-onset motor neuron disease uniformly produce loss of activity through decreased protein stability of this endosomal GEF [<a class="bk_pop" href="#iahsp.REF.yamanaka.2003.16041">Yamanaka et al 2003</a>].</p><p>Some reported <i>ALS2</i> pathogenic variants causing motor neuron diseases are reported to be associated with a loss of protein stability [<a class="bk_pop" href="#iahsp.REF.yamanaka.2003.16041">Yamanaka et al 2003</a>], which leads to reduction or loss of all three potential GEF domains. A current research focus is the role of alsin as a Rab5-GEF and its involvement in endosomal dynamics. It is premature to discount roles for the other GEF domains as well as corresponding GTPases in understanding the role of alsin in the death of upper motor neurons beginning in early postnatal life.</p></div><div id="iahsp.References"><h2 id="_iahsp_References_">References</h2><div id="iahsp.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.alsaif.2011.913">Al-Saif A, Al-Mohanna F, Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. <span><span class="ref-journal">Ann Neurol. </span>2011;<span class="ref-vol">70</span>:913–9.</span> [<a href="/pubmed/21842496" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21842496</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.alsaif.2012.510">Al-Saif A, Bohlega S, Al-Mohanna F. Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. <span><span class="ref-journal">Ann Neurol. </span>2012;<span class="ref-vol">72</span>:510–6.</span> [<a href="/pubmed/23109145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23109145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.ben_hamida.1990.347">Ben Hamida M, Hentati F, Ben Hamida C. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. <span><span class="ref-journal">Brain. </span>1990;<span class="ref-vol">113</span>:347–63.</span> [<a href="/pubmed/2328408" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2328408</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.brugman.2007.702">Brugman F, Eymard-Pierre E, van den Berg LH, Wokke JH, Gauthier-Barichard F, Boespflug-Tanguy O. Adult-onset primary lateral sclerosis is not associated with mutations in the ALS2 gene. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">69</span>:702–4.</span> [<a href="/pubmed/17698795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17698795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.cai.2005.7567">Cai H, Lin X, Xie C, Laird FM, Lai C, Wen H, Chiang HC, Shim H, Farah MH, Hoke A, Price DL, Wong PC. Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. <span><span class="ref-journal">J Neurosci. </span>2005;<span class="ref-vol">25</span>:7567–74.</span> [<a href="/pmc/articles/PMC2364727/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2364727</span></a>] [<a href="/pubmed/16107644" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16107644</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.chen.2004.1128">Chen Y-Z, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dirick I, Abel A, Kennerson ML, Rabin BA, Nicholson GA, Auer-Grumbach M, Wagner K, De Jonghe P, Griffin JW, Fischbeck KH, Timmerman V, Cornblath DR, Chance PF. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:1128–35.</span> [<a href="/pmc/articles/PMC1182077/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182077</span></a>] [<a href="/pubmed/15106121" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15106121</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.deng.2007.2911">Deng HX, Zhai H, Fu R, Shi Y, Gorrie GH, Yang Y, Liu E, Dal Canto MC, Mugnaini E, Siddique T. Distal axonopathy in an alsin-deficient mouse model. <span><span class="ref-journal">Hum Mol Genet. </span>2007;<span class="ref-vol">16</span>:2911–20.</span> [<a href="/pubmed/17855450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17855450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.gascon.1995.313">Gascon GG, Chavis P, Yaghmour A, Stigsby B, Shums A, Ozand P, Siddique T. Familial childhood primary lateral sclerosis with associated gaze paresis. <span><span class="ref-journal">Neuropediatrics. </span>1995;<span class="ref-vol">26</span>:313–9.</span> [<a href="/pubmed/8719747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8719747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.groslouis.2008.2691">Gros-Louis F, Kriz J, Kabashi E, McDearmid J, Millecamps S, Urushitani M, Lin L, Dion P, Zhu Q, Drapeau P, Julien JP, Rouleau GA. Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:2691–702.</span> [<a href="/pubmed/18558633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18558633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.hadano.2006.233">Hadano S, Benn SC, Kakuta S, Otomo A, Sudo K, Kunita R, Suzuki-Utsunomiya K, Mizumura H, Shefner JM, Cox GA, Iwakura Y, Brown RH Jr, Ikeda JE. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. <span><span class="ref-journal">Hum Mol Genet. </span>2006;<span class="ref-vol">15</span>:233–50.</span> [<a href="/pubmed/16321985" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16321985</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.hadano.2007.74">Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE. Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration. <span><span class="ref-journal">Neurochem Int. </span>2007;<span class="ref-vol">51</span>:74–84.</span> [<a href="/pubmed/17566607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17566607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.hentati.1994.425">Hentati A, Bejaoui K, Pericak-Vance MA, Hentati F, Speer MC, Hung WY, Figlewicz DA, Haines J, Rimmler J, Ben Hamida C, et al.  Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. <span><span class="ref-journal">Nat Genet. </span>1994;<span class="ref-vol">7</span>:425–8.</span> [<a href="/pubmed/7920663" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7920663</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.hentati.1998.55">Hentati A, Ouahchi K, Pericak-Vance MA, Nijhawan D, Ahmad A, Yang Y, Rimmler J, Hung W, Schlotter B, Ahmed A, Ben Hamida M, Hentati F, Siddique T. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. <span><span class="ref-journal">Neurogenetics. </span>1998;<span class="ref-vol">2</span>:55–60.</span> [<a href="/pubmed/9933301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9933301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.kanekura.2005.4532">Kanekura K, Hashimoto Y, Kita Y, Sasabe J, Aiso S, Nishimoto I, Matsuoka M. A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:4532–43.</span> [<a href="/pubmed/15579468" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15579468</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.kress.2005.800">Kress JA, K&#x000fc;hnlein P, Winter P, Ludolph AC, Kassubek J, M&#x000fc;ller U, Sperfeld AD. Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">58</span>:800–3.</span> [<a href="/pubmed/16240357" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16240357</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.kunita.2004.38626">Kunita R, Otomo A, Mizumura H, Suzuki K, Showguchi-Miyata J, Yanagisawa Y, Hadano S, Ikeda JE. Homo-oligomerization of ALS2 through its unique carboxyl-terminal regions is essential for the ALS2-associated Rab5 guanine nucleotide exchange activity and its regulatory function on endosome trafficking. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:38626–35.</span> [<a href="/pubmed/15247254" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15247254</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.kunita.2007.16599">Kunita R, Otomo A, Mizumura H, Suzuki-Utsunomiya K, Hadano S, Ikeda JE. The Rab5 activator ALS2/alsin acts as a novel Rac1 effector through Rac1-activated endocytosis. <span><span class="ref-journal">J Biol Chem. </span>2007;<span class="ref-vol">282</span>:16599–611.</span> [<a href="/pubmed/17409386" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17409386</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.lesca.2003.674">Lesca G, Eymard-Pierre E, Santorelli FM, Cusmai R, Di Capua M, Valente EM, Attia-Sobol J, Plauchu H, Leuzzi V, Ponzone A, Boespflug-Tanguy O, Bertini E. Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:674–82.</span> [<a href="/pubmed/12601111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12601111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.marangi.2015.75">Marangi G, Traynor BJ. Genetic causes of amyotrophic lateral sclerosis: New genetic analysis methodologies entailing new opportunities and challenges. <span><span class="ref-journal">Brain Res. </span>2015;<span class="ref-vol">1607</span>:75–93.</span> [<a href="/pmc/articles/PMC5916786/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5916786</span></a>] [<a href="/pubmed/25316630" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25316630</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.mintchev.2009.28">Mintchev N, Zamba-Papanicolaou E, Kleopa KA, Christodoulou K. A novel ALS2 splice-site mutation in a Cypriot juvenile-onset primary lateral sclerosis family. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:28–32.</span> [<a href="/pubmed/19122027" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19122027</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.otomo.2003.1671">Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, Nishijima H, Showguchi-Miyata J, Yanagisawa Y, Kohiki E, Suga E, Yasuda M, Osuga H, Nishimoto T, Narumiya S, Ikeda JE. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:1671–87.</span> [<a href="/pubmed/12837691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12837691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.pringle.1992.495">Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. <span><span class="ref-journal">Brain. </span>1992;<span class="ref-vol">115</span>:495–520.</span> [<a href="/pubmed/1606479" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1606479</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.sheerin.2014.1065">Sheerin U-M, Schneider SA, Carr L, Deuschl G, Hopfner F, Stamelou M, Wood NW, Bhatia KP. ALS2 mutations. Juvenile amyotrophic lateral sclerosis and generalized dystonia. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:1065–7.</span> [<a href="/pmc/articles/PMC3962990/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3962990</span></a>] [<a href="/pubmed/24562058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24562058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.shirakawa.2009.2124">Shirakawa K, Suzuki H, Ito M, Kono S, Uchiyama T, Ohashi T, Miyajima H. Novel compound heterozygous ALS2 mutations cause juvenile amyotrophic lateral sclerosis in Japan. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:2124–6.</span> [<a href="/pubmed/20018642" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20018642</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.topp.2004.24612">Topp JD, Gray NW, Gerard RD, Horazdovsky BF. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:24612–23.</span> [<a href="/pubmed/15033976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15033976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.verschuurenbemelmans.2008.1407">Verschuuren-Bemelmans CC, Winter P, Sival DA, Elting JW, Brouwer OF, M&#x000fc;ller U. Novel homozygous ALS2 nonsense mutation (p.Gln715X) in sibs with infantile-onset ascending spastic paralysis: the first cases from northwestern Europe. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:1407–11.</span> [<a href="/pubmed/18523452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18523452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.yamanaka.2006.95">Yamanaka K, Miller TM, McAlonis-Downes M, Chun SJ, Cleveland DW. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">60</span>:95–104.</span> [<a href="/pubmed/16802286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16802286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.yamanaka.2003.16041">Yamanaka K, Vande Velde C, Eymard-Pierre E, Bertini E, Boespflug-Tanguy O, Cleveland DW. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:16041–6.</span> [<a href="/pmc/articles/PMC307689/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC307689</span></a>] [<a href="/pubmed/14668431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14668431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iahsp.REF.yang.2001.160">Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, Hung WY, Ouahchi K, Yan J, Azim AC, Cole N, Gascon G, Yagmour A, Ben-Hamida M, Pericak-Vance M, Hentati F, Siddique T. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:160–5.</span> [<a href="/pubmed/11586297" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11586297</span></a>]</div></li></ul></div></div><div id="iahsp.Chapter_Notes"><h2 id="_iahsp_Chapter_Notes_">Chapter Notes</h2><div id="iahsp.Author_History"><h3>Author History</h3><p>Enrico S Bertini, MD; Ospedale Bambino Gesu, Rome (2005-2016)<br />Odile Boespflug-Tanguy, MD, PhD; Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale, Clermont-Ferrand (2005-2016)<br />Don W Cleveland, PhD, University of California San Diego (2005-2016)<br />Eleonore Eymard-Pierre, PhD; Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale, Clermont-Ferrand (2005-2016)<br />Richard W Orrell, BSc, MD, FRCP (2016-present)<br />Koji Yamanaka, MD, PhD; RIKEN Brain Science Institute, Wako (2005-2016)</p></div><div id="iahsp.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>28 January 2016 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 April 2013 (tb) Revision: information on mutations in <i>ERLIN2</i> and <i>SIGMAR1</i> added to <a href="#iahsp.Differential_Diagnosis">Differential Diagnosis</a></div></li><li class="half_rhythm"><div>10 February 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 October 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>16 December 2004 (esb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1243</span><span class="label">PMID: <a href="/pubmed/20301421" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301421</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alk-nbs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ankrd26/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1243&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1243/?report=reader">PubReader</a></li><li><a href="/books/NBK1243/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1243" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1243" style="display:none" title="Cite this Page"><div class="bk_tt">Orrell RW. ALS2-Related Disorders. 2005 Oct 21 [Updated 2016 Jan 28]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1243/pdf/Bookshelf_NBK1243.pdf">PDF version of this page</a> (199K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#iahsp.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#iahsp.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#iahsp.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#iahsp.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#iahsp.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#iahsp.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#iahsp.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#iahsp.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#iahsp.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#iahsp.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#iahsp.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#iahsp.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57679[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALS2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1243+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1476368" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1476368" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1476368" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1476368" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12145748" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene.</a><span class="source">[Am J Hum Genet. 2002]</span><div class="brieflinkpop offscreen_noflow">Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Eymard-Pierre E, Lesca G, Dollet S, Santorelli FM, di Capua M, Bertini E, Boespflug-Tanguy O. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2002 Sep; 71(3):518-27. Epub 2002 Jul 26.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30128655" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical presentation and natural history of infantile-onset ascending spastic paralysis from three families with an ALS2 founder variant.</a><span class="source">[Neurol Sci. 2018]</span><div class="brieflinkpop offscreen_noflow">Clinical presentation and natural history of infantile-onset ascending spastic paralysis from three families with an ALS2 founder variant.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Helal M, Mazaheri N, Shalbafan B, Malamiri RA, Dilaver N, Buchert R, Mohammadiasl J, Golchin N, Sedaghat A, Mehrjardi MYV, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurol Sci. 2018 Nov; 39(11):1917-1925. Epub 2018 Aug 21.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301718" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30543385" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> AP-4-Associated Hereditary Spastic Paraplegia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> AP-4-Associated Hereditary Spastic Paraplegia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ebrahimi-Fakhari D, Behne R, Davies AK, Hirst J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24315819" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Infantile-onset ascending hereditary spastic paraplegia with bulbar involvement due to the novel ALS2 mutation c.2761C&amp;gt;T.</a><span class="source">[Gene. 2014]</span><div class="brieflinkpop offscreen_noflow">Infantile-onset ascending hereditary spastic paraplegia with bulbar involvement due to the novel ALS2 mutation c.2761C&amp;gt;T.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wakil SM, Ramzan K, Abuthuraya R, Hagos S, Al-Dossari H, Al-Omar R, Murad H, Chedrawi A, Al-Hassnan ZN, Finsterer J, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Gene. 2014 Feb 15; 536(1):217-20. Epub 2013 Dec 4.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301421" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301421" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042b4139a66ee2bac6dbe4">ALS2-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">ALS2-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:38:41-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88BA18E0425F9100000000025D00E5&amp;ncbi_session=CE88BA18E042B401_0605SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1243%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1243&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1243/&amp;ncbi_pagename=ALS2-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88BA18E042B401_0605SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>